Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mycobacterium Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06553508
What this trial is testing

Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 Days

Who this might be right for
Bursa; TuberculousHip BursitisDeep Gluteal Syndrome+1 more
Ankara City Hospital Bilkent 104
Testing effectiveness (Phase 2)Study completedNCT00919776
What this trial is testing

Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum

Who this might be right for
Leprosy
London School of Hygiene and Tropical Medicine 20
Post-approval studies (Phase 4)Study completedNCT01637558
What this trial is testing

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Who this might be right for
TuberculosisHIV
University of Cape Town 200
Testing effectiveness (Phase 2)WithdrawnNCT05539989
What this trial is testing

Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Who this might be right for
TuberculosisHIV Infections
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Not applicableStudy completedNCT03470233
What this trial is testing

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Korea Otsuka Pharmaceutical Co., Ltd. 149
Not applicableLooking for participantsNCT07086820
What this trial is testing

Window Prophylaxis for Pediatric Tuberculosis Prevention Trial

Who this might be right for
Tuberculosis InfectionHousehold ContactsChildren+3 more
Pontificia Universidad Catolica de Chile 647
Not applicableStudy completedNCT01311999
What this trial is testing

Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis

Who this might be right for
To Predict the Potential of Development of Active Tuberculosis in Those Receiving Long-term Dialysis by Using Interferon-gamma Release Assy
National Taiwan University Hospital 234
Large-scale testing (Phase 3)Looking for participantsNCT06441006
What this trial is testing

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco 400
Testing effectiveness (Phase 2)UnknownNCT06305104
What this trial is testing

Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.

Who this might be right for
Tuberculosis
Chengdu CoenBiotech Co., Ltd 420
Not applicableStudy completedNCT04752592
What this trial is testing

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

Who this might be right for
Tuberculosis, Pulmonary
Norwegian Institute of Public Health 9,097
Testing effectiveness (Phase 2)Study completedNCT03988933
What this trial is testing

2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

Who this might be right for
Latent Tuberculosis
McGill University Health Centre/Research Institute of the McGill University Health Centre 1,368
Not applicableStudy completedNCT01130311
What this trial is testing

Replacement of Vitamin D in Patients With Active Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Aga Khan University 259
Not applicableNot Yet RecruitingNCT07677904
What this trial is testing

Tuberculosis Clinical Registry in Europe

Who this might be right for
Tuberculosis
Research Center Borstel 1,000
Large-scale testing (Phase 3)UnknownNCT02060006
What this trial is testing

TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial

Who this might be right for
Tuberculosis
University of Stellenbosch 200
Large-scale testing (Phase 3)UnknownNCT00216385
What this trial is testing

A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Institut de Recherche pour le Developpement 2,070
Not applicableStudy completedNCT04995406
What this trial is testing

Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis

Who this might be right for
TUBERCULOSIS, PULMONARY
BioMérieux 722
Not applicableStudy completedNCT01766830
What this trial is testing

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

Who this might be right for
Visceral LeishmaniasisHuman African TrypanosomiasisEnteric Fever+9 more
University Hospital, Geneva 1,927
Post-approval studies (Phase 4)Looking for participantsNCT05493267
What this trial is testing

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Who this might be right for
MDR-TBImmunotherapy
Shanghai Pulmonary Hospital, Shanghai, China 30
Not applicableStudy completedNCT02581579
What this trial is testing

Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection

Who this might be right for
Tuberculosis
Manresana de Micobacteriologia, SL 24
Testing effectiveness (Phase 2)Study completedNCT02619994
What this trial is testing

Treatment Shortening of MDR-TB Using Existing and New Drugs

Who this might be right for
Tuberculosis, Multidrug-Resistant
Seoul National University Hospital 214
Next Page